- Conditions: Atherosclerosis; LDL-hypercholesterolemia
Intervention: Drug: mipomersen
Sponsors: Ludwig-Maximilians - University of Munich; Ludwig-Maximilians - University of Munich
Not yet recruiting - verified May 2012 - Condition: Hypercholesterolemia
Interventions: Dietary Supplement: Fabricated foods with lupin protein; Dietary Supplement: Mannitol; Dietary Supplement: Arginine; Dietary Supplement: Fabricated foods with milk protein
Sponsors: University of Jena; University of Jena; German Federal Ministry of Education and Research
Not yet recruiting - verified May 2012 - Condition: Atherosclerosis
Interventions: Drug: BMS-962476; Drug: BMS-962476; Drug: BMS-962476; Drug: BMS-962476; Drug: BMS-962476; Drug: BMS-962476; Drug: BMS-962476; Drug: BMS-962476; Drug: Placebo matching with BMS-962476; Drug: Placebo matching with BMS-962476
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Not yet recruiting - verified April 2012 - Conditions: Mucopolysaccharidosis I; Mucopolysaccharidosis VI; Adrenoleukodystrophy; Niemann-Pick Disease; Metachromatic Leukodystrophy; Wolman Disease; Krabbe's Disease; Gaucher's Disease; Fucosidosis; Batten Disease; Severe Aplastic Anemia; Diamond-Blackfan Anemia; Amegakaryocytic Thrombocytopenia; Myelodysplastic Syndrome; Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia
Intervention: Drug: Human Placental Derived Stem Cell
Sponsors: New York Medical College; New York Medical College
Not yet recruiting - verified April 2012 - Condition: Cardiovascular Disease
Intervention: Dietary Supplement: High/ Low Epicatechin Apples/ Apple Extract/ Granules
Sponsors: Queen's University, Belfast; Queen's University, Belfast
Recruiting - verified April 2012 - Conditions: Atherosclerosis; Hypercholesterolemia
Intervention: Dietary Supplement: Oat bran
Sponsors: Instituto de Cardiologia do Rio Grande do Sul; Instituto de Cardiologia do Rio Grande do Sul; Quaker, Inc.; CNPq Universal
Recruiting - verified April 2012 - Condition: Sitosterolemia
Intervention: Drug: Ezetimibe
Sponsors: University of Manitoba; University of Manitoba
Recruiting - verified April 2012 - Conditions: Cholesterol Level; HDL Level; LDL Level; TG Level
Intervention: Dietary Supplement: red rice supplement
Sponsors: Universiteit Antwerpen; Universiteit Antwerpen
Not yet recruiting - verified March 2012 - Condition: Hypercholesterolemia
Interventions: Drug: Amoxicillin; Drug: Placebo capsule
Sponsors: Maastricht University Medical Center; Maastricht University Medical Center
Recruiting - verified March 2012 - Conditions: Stroke; Transient Ischemic Attack; Hypertension
Intervention: Drug: all approved antihypertensive drugs; all approved statins
Sponsors: Istituto Auxologico Italiano; Istituto Auxologico Italiano; European Society of Hypertension; Chinese Hypertension League
Not yet recruiting - verified March 2012 - Conditions: Hypertension; Hypercholesterolemia; Type II Diabetes; Obesity; Inflammation
Intervention: Other: vegetable
Sponsors: University of Guelph; University of Guelph; Ontario Ministry of Agriculture, Food and Rural Affairs
Not yet recruiting - verified March 2012 - Conditions: Hypercholesterolemia; Cardiovascular Disease; CRP
Intervention: Other: Standardized soy containing muffin
Sponsors: Guelph Food Research Centre; Guelph Food Research Centre; University of Guelph; Glycemic Index Laboratories, Inc; Canadian Centre for Agri-food Research in Health and Medicine
Not yet recruiting - verified March 2012 - Condition: Dyslipidemias
Intervention: Other: Pharmacist care
Sponsors: University of Alberta; University of Alberta; AstraZeneca
Recruiting - verified April 2012 - Conditions: Coronary Artery Disease; Atherosclerosis
Intervention: Drug: ACP-501
Sponsors: Alphacore Pharma, LLC; Alphacore Pharma, LLC; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2012 - Condition: Parkinson's Disease
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified February 2012 - Conditions: Cardiovascular Disease; Oxidative Stress
Interventions: Dietary Supplement: Chokeberry Extract; Dietary Supplement: Placebo capsule; Dietary Supplement: Chokeberry extract capsule, acute
Sponsors: University of Connecticut; University of Connecticut
Not yet recruiting - verified February 2012 - Condition: Saphenous Vein Graft Disease
Interventions: Drug: Atorvastatin 80 mg daily; Drug: Atorvastatin 10 mg daily
Sponsors: Boca Raton Regional Hospital; Boca Raton Regional Hospital; Pfizer
Recruiting - verified March 2012 - Conditions: Cholesterol Ester Storage Disease(CESD); Lysosomal Acid Lipase Deficiency
Intervention:
Sponsors: Synageva BioPharma Corp.; Synageva BioPharma Corp.
Recruiting - verified February 2012 - Conditions: Foot Ulcers; Arteriosclerosis Obliterans; Diabetes Mellitus; LDL-apheresis
Intervention: Device: LDL-apheresis
Sponsors: Universita di Verona; Universita di Verona
Recruiting - verified February 2012 - Condition: Hypercholesterolemia
Interventions: Drug: AMG 145; Other: Placebo
Sponsors: Amgen; Amgen
Recruiting - verified January 2012 - Conditions: Type 2 Diabetes; African American; Cholesterol; Lipoprotein; Apolipoprotein
Intervention:
Sponsors: Mercer University; Mercer University; Kathryn Momary, PharmD Mercer University College of Pharmacy and Health Sciences; Dawn Smiley, MD Emory University School of Medicine; H. Robert Superko, M.D., Vice President, Chief of Medical Affairs Celera
Recruiting - verified December 2011 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: 1mg Glimepiride/10mg Atorvastatin FDC; Drug: 2mg Glimepiride/10mg Atorvastatin FDC; Drug: 3mg Glimepiride/10mg Atorvastatin FDC; Drug: 4mg Glimepiride/10mg Atorvastatin FDC; Drug: 1mg Glimepiride/20mg Atorvastatin FDC; Drug: 2mg Glimepiride/20mg Atorvastatin FDC; Drug: 3mg Glimepiride/20mg Atorvastatin FDC; Drug: 4mg Glimepiride/20mg Atorvastatin FDC; Drug: 1mg Glimepiride; Drug: 2mg Glimepiride; Drug: 3mg Glimepiride; Drug: 4mg Glimepiride; Drug: 10mg Atorvastatin; Drug: 20mg Atorvastatin
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified February 2012 - Condition: Cardiovascular Diseases
Interventions: Drug: AMR101; Drug: Placebo
Sponsors: Amarin Pharma Inc.; Amarin Pharma Inc.
Recruiting - verified March 2012 - Conditions: Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
Interventions: Biological: EGEN-001; Drug: pegylated liposomal doxorubicin hydrochloride; Genetic: RNA analysis; Other: laboratory biomarker analysis
Sponsors: National Cancer Institute (NCI); Gynecologic Oncology Group; National Cancer Institute (NCI)
Not yet recruiting - verified April 2012 - Condition: Hypercholesterolaemia
Intervention:
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified April 2012 - Conditions: Dyslipidemia; Healthy Volunteers
Intervention: Drug: TAP311
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Conditions: Hypercholesterolemia; Coronary Heart Disease
Interventions: Drug: mipomersen sodium 200 mg; Drug: Placebo; Drug: mipomersen sodium 70 mg
Sponsors: Genzyme; Genzyme
Recruiting - verified December 2011 - Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Metformin; Drug: Placebo
Sponsors: University of Glasgow; University of Glasgow; NHS Greater Glasgow and Clyde; Juvenile Diabetes Research Foundation; Imperial College London; University of Wisconsin School of Medicine and Public Health; University of Dundee; Merck Serono S.A., Geneva; Itamar-Medical, Israel; University of Western Ontario, Canada; University of Melbourne; Steno Diabetes Center; Maastricht University Medical Center
Recruiting - verified January 2012 - Condition: Risk Reduction Behavior
Interventions: Dietary Supplement: assessment of efficacy of Benecol yogurt; Dietary Supplement: Placebo Yogurt; Dietary Supplement: yogurt
Sponsors: CES University; Jose María Maya Mejía
Not yet recruiting - verified October 2011 - Condition: Lung Cancer
Interventions: Drug: DOTAP:Chol-fus1; Drug: Erlotinib; Drug: Dexamethasone; Drug: Diphenhydramine
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; Convergen LifeSciences, Inc.
Not yet recruiting - verified March 2012 - Condition: Cholesterol Embolism Systemic
Interventions: Drug: prednisone; Other: placebo
Sponsors: University Hospital, Toulouse; University Hospital, Toulouse; Ministry of Health, France
Recruiting - verified October 2011 - Condition: Hypercholesterolemia
Interventions: Drug: AMG 145 and standard of care; Other: Standard of care
Sponsors: Amgen; Amgen
Recruiting - verified May 2012 - Condition: Smith-Lemli-Opitz Syndrome
Interventions: Drug: Simvastatin; Dietary Supplement: Lactose
Sponsors: Oregon Health and Science University; Oregon Health and Science University; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2012 - Condition: HIV-1 Infection
Interventions: Drug: Niacin; Drug: Aspirin; Drug: Fenofibrate
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified October 2011 - Condition: Hyperlipidemia
Interventions: Drug: LY3015014 (intravenously); Drug: Placebo (intravenously); Drug: LY3015014 (subcutaneously); Drug: Placebo (subcutaneously)
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Conditions: Cardiovascular Disease; Dyslipidemia; Insulin Resistance; Inflammation
Interventions: Other: High saturated fat red meat diet; Other: High saturated fat non-meat diet; Other: High saturated fat white meat diet; Other: Low saturated fat red meat diet; Other: Low saturated fat white meat diet; Other: Low saturated fat non meat diet
Sponsors: Children's Hospital & Research Center Oakland; Children's Hospital & Research Center Oakland; National Institutes of Health (NIH); National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - verified November 2011 - Conditions: Diabetes Mellitus, Type 2; Hypertension; Dyslipidemias; Cholesterol, LDL; Comorbitdity
Interventions: Other: Facilitation; Other: Passive diffusion (usual implementation strategy)
Sponsors: Fonds de la Recherche en Santé du Québec; Fonds de la Recherche en Santé du Québec; Université de Montréal
Recruiting - verified August 2011 - Condition: Healthy
Intervention: Dietary Supplement: Palm Mid Fraction, Shea Butter, High Oleic Sunflower Oil
Sponsors: Malaysia Palm Oil Board; Malaysia Palm Oil Board; International Medical University
Recruiting - verified August 2011 - Condition: Smith-Lemi-Opitz Syndrome
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2012 - Condition: Dyslipidemia
Interventions: Drug: ERN/LRPT; Drug: placebo
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Conditions: Blood Pressure Check (Hypertension Screening); Cholesterol Test (Lipid Disorder Screening)
Interventions: Behavioral: Scratchoff Prompt: Name of Test; Behavioral: Scratchoff Prompt: Call to Action; Behavioral: Control
Sponsors: University of Pennsylvania; University of Pennsylvania
Not yet recruiting - verified June 2011 - Conditions: Cardiovascular Disease; Dyslipidemia; Blood Pressure
Interventions: Other: Dietary Intervention; Other: Dietary Intervention; Other: Dietary Intervention
Sponsors: Children's Hospital & Research Center Oakland; Children's Hospital & Research Center Oakland; Dairy Management Inc.
Recruiting - verified August 2011 - Conditions: Blood Pressure; Heart Rate and Rhythm Disorders; Hypoglycemia; Lactate; Nitrate; Cholesterol (Total and HDL); Abnormality in Fetal Heart Rate or Rhythm, Unspecified as to Episode of Care
Intervention: Other: Physical exercise
Sponsors: Instituto Materno Infantil Prof. Fernando Figueira; Instituto Materno Infantil Prof. Fernando Figueira; Professor Fernando Figueira Integral Medicine Institute; Federal University of Paraíba
Not yet recruiting - verified June 2011 - Condition: ST-Segment Elevation Myocardial Infarction
Interventions: Drug: Ezetimibe; Drug: Placebo
Sponsors: Odense University Hospital; Odense University Hospital
Recruiting - verified June 2011 - Conditions: Lysosomal Acid Lipase Deficiency; Wolman Disease
Intervention: Drug: SBC-102
Sponsors: Synageva BioPharma Corp.; Synageva BioPharma Corp.
Recruiting - verified October 2011 - Condition: Smith-Lemli-Opitz Syndrome
Intervention: Dietary Supplement: Cholesterol supplementation
Sponsors: Oregon Health and Science University; Oregon Health and Science University
Recruiting - verified February 2012 - Conditions: Insulin Resistance; Obesity; Dyslipidemia
Intervention: Dietary Supplement: Citrus Flavonoids
Sponsors: University of Nottingham; University of Nottingham; Florida Department of Citrus
Recruiting - verified January 2012 - Conditions: Lysosomal Acid Lipase Deficiency; Wolman Disease
Intervention:
Sponsors: Synageva BioPharma Corp.; Synageva BioPharma Corp.
Recruiting - verified July 2011 - Condition: Peripheral Arterial Disease
Interventions: Drug: Niacin/Laropiprant combination; Drug: Sugar pill
Sponsors: Bayside Health; Bayside Health; National Health and Medical Research Council, Australia
Recruiting - verified July 2011 - Condition: Hyperlipidemia
Interventions: Drug: XueZhiKang (XZK), a botanic product with multiple components; Drug: Placebo
Sponsors: Beijing Peking University WBL Biotech Co., Ltd.; Beijing Peking University WBL Biotech Co., Ltd.
Recruiting - verified November 2011 - Condition: Colorectal Cancer
Intervention: Drug: EGEN-001-301
Sponsors: EGEN, Inc.; EGEN, Inc.
Recruiting - verified October 2011 - Condition: Dyslipidemia
Intervention: Dietary Supplement: Resveratrol capsules
Sponsors: Maastricht University Medical Center; Maastricht University Medical Center; DSM Nutritional Products, Ltd
Recruiting - verified June 2011 - Condition: Acute Coronary Syndrome
Intervention:
Sponsors: McGill University Health Center; McGill University Health Center; McGill University
Recruiting - verified September 2011 - Condition: Hypercholesterolemia
Interventions: Drug: Psyllium husks; Dietary Supplement: Isolated soy protein; Dietary Supplement: Isolated whey protein; Other: Microcrystalline cellulose
Sponsors: Aalborg Hospital; Aalborg Hospital
Recruiting - verified June 2011 - Conditions: Ischemic Stroke; Transient Ischemic Attack; Atherosclerotic Stenosis
Interventions: Procedure: Target : 100 mg/dL (+/-10 mg/dL); Procedure: 70 mg/dL
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris; Pfizer; AstraZeneca; Merck
Recruiting - verified December 2009 - Conditions: Drug Eluting Stent; Coronary Artery Disease; Polymorphism; Cholesterol; Biomarker
Intervention:
Sponsors: The Catholic University of Korea; The Catholic University of Korea; Seoul St. Mary's Hospital; Yeouido St.Mary's Hospital; UiJeungbu St.Mary's Hospital; Bucheon St.Mary's Hospital; St.Paul's Hospital, Korea; Incheon St.Mary's Hospital; St.Vincent's Hospital of Korea; Daejeon St.Mary's Hospital
Recruiting - verified July 2010 - Condition: HIV-1 Infection
Interventions: Drug: atorvastatin; Drug: atorvastatin
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID); Pfizer
Recruiting - verified September 2011 - Condition: Cardiovascular Disease
Interventions: Other: Avocado Diet; Other: Lower-Fat Diet; Other: Moderate Fat Diet
Sponsors: Penn State University; Penn State University; Hass Avocado Board
Recruiting - verified July 2011 - Conditions: Primary Hypercholesterolemia; Mixed Dyslipidemia
Interventions: Drug: Extended-release niacin/laropiprant (ERN/LRPT); Drug: Placebo
Sponsors: Merck; Merck
Recruiting - verified April 2012 - Conditions: Atherosclerosis; Hypercholesterolemia
Interventions: Drug: LDL. Cholesterol (Statin Drugs); Drug: HMG-CoA Reductase Inhibitors
Sponsors: National Institutes of Health Clinical Center (CC); National Institutes of Health Clinical Center (CC)
Recruiting - verified July 2011 - Condition: Healthy Volunteers
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified April 2012 - Condition: Cardiovascular Diseases
Intervention:
Sponsors: Abbott; Abbott; QUASY
Recruiting - verified April 2012 - Condition: Left Ventricular Hypertrophy
Intervention: Other: Exercise training, women, marathon
Sponsors: University of California, San Francisco; University of California, San Francisco
Recruiting - verified March 2012 - Condition: Hypercholesterolemia
Interventions: Drug: ezetimibe (+) atorvastatin; Drug: Comparator: ezetimibe (+) atorvastatin; Drug: Comparator: atorvastatin, switching to ezetimibe (+) atorvastatin; Drug: Comparator: atorvastatin; Drug: Comparator: rosuvastatin, switching to ezetimibe (+) atorvastatin; Drug: Comparator: rosuvastatin
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Conditions: Diabetes; Heart Disease; Hypertension
Intervention: Behavioral: CARIÑO Project
Sponsors: University of Miami; University of Miami; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified August 2011 - Condition: Cardiovascular Disease
Interventions: Other: Placebo; Drug: Alpha-CD
Sponsors: National Institutes of Health Clinical Center (CC); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified January 2012 - Conditions: Rheumatoid Arthritis; Insulin Resistance
Intervention: Drug: Hydroxychloroquine
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified February 2012 - Conditions: Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
Interventions: Biological: EGEN-001; Other: laboratory biomarker analysis
Sponsors: National Cancer Institute (NCI); Gynecologic Oncology Group; National Cancer Institute (NCI)
Recruiting - verified March 2012 - Conditions: Rheumatoid Arthritis; Cardiovascular Disease
Intervention:
Sponsors: University of Arkansas; University of Arkansas
Recruiting - verified December 2011 - Conditions: Uterine Inertia; Dystocia
Intervention: Biological: Whole blood sampling
Sponsors: Centre Hospitalier Universitaire de Nīmes; Centre Hospitalier Universitaire de Nīmes
Recruiting - verified June 2011 - Condition: Cardiovascular Disease
Intervention: Other: Almonds
Sponsors: Penn State University; Penn State University; Almond Board of California
Recruiting - verified June 2011 - Conditions: Schizophrenia; Schizoaffective Disorders; Schizophreniform Disorders
Interventions: Drug: Pravastatin; Drug: Placebo
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Stanley Medical Research Institute; North Suffolk Mental Health Association
Recruiting - verified April 2012 - Condition: Autism Spectrum Disorder
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified September 2011 - Condition: Hypercholesterolemia
Interventions: Behavioral: stage-matched intervention; Behavioral: framing effects intervention; Behavioral: attention placebo intervention
Sponsors: Narrows Institute for Biomedical Research; Narrows Institute for Biomedical Research
Recruiting - verified July 2010 - Conditions: Stroke; Transient Ischemic Attack
Interventions: Behavioral: tailored intervention; Behavioral: attention placebo
Sponsors: Narrows Institute for Biomedical Research; Narrows Institute for Biomedical Research
Recruiting - verified September 2011 - Condition: Amyotrophic Lateral Sclerosis
Interventions: Dietary Supplement: Oxepa; Dietary Supplement: Jevity 1.5; Dietary Supplement: Jevity 1.0
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Muscular Dystrophy Association
Recruiting - verified February 2012 - Conditions: Autism; Asperger Disorder; PDD-NOS
Intervention: Other: Cholesterol
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified April 2012 - Conditions: Ischemic Stroke; Transient Ischemic Attacks
Interventions: Drug: Antihypertensive agents and lipid lowering therapy; Other: Usual Care
Sponsors: University of Alberta; University of Alberta; Heart and Stroke Foundation; Alberta Heritage Foundation for Medical Research
Recruiting - verified December 2011 - Conditions: Hypercholesterolemia; HIV Infections
Interventions: Drug: Ezetimibe; Drug: Rosuvastatin (standard care)
Sponsors: University of British Columbia; University of British Columbia; Merck Frosst-Schering Pharma, G.P.
Recruiting - verified November 2011 - Condition: High Triglycerides and Cholesterol
Intervention: Drug: Lovaza
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; GlaxoSmithKline
Recruiting - verified July 2011 - Conditions: Myocardial Infarction; Angina; Coronary Artery Disease; Myocardial Ischemia
Intervention: Device: Intravascular Near Infrared Spectroscopy
Sponsors: InfraReDx; InfraReDx
Recruiting - verified March 2012 - Condition: HDL Cholesterol
Interventions: Drug: Simvastatin; Drug: Atorvastatin 80 mg
Sponsors: Oregon Health and Science University; Oregon Health and Science University; Merck; Oregon State University; Indiana University
Recruiting - verified August 2008 - Conditions: Hypercholesterolemia; Vitamin D Deficiency
Interventions: Drug: Vitamin D3 dose titration; Other: Placebo
Sponsors: Jewish Home, San Francisco; Jewish Home, San Francisco; National Institute on Aging (NIA)
Recruiting - verified March 2012 - Condition: Statin Induced Myalgia
Interventions: Drug: Coenzyme Q 10; Drug: Placebo control
Sponsors: Hadassah Medical Organization; Hadassah Medical Organization
Recruiting - verified September 2010 - Conditions: HIV Infections; Hyperlipidemia
Intervention: Drug: Atorvastatin
Sponsors: International Maternal Pediatric Adolescent AIDS Clinical Trials Group; International Maternal Pediatric Adolescent AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified May 2012 - Condition: Sitosterolemia
Intervention: Behavioral: High/Low Sitosterol
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified August 2011 - Condition: Healthy
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Environmental Health Sciences (NIEHS)
Recruiting - verified June 2011 - Conditions: Adrenoleukodystrophy; Metachromatic Leukodystrophy; Globoid Cell Leukodystrophy; Tay Sachs Disease; Sandhoffs Disease; Wolman Disease; I-Cell Disease; Sanfilippo Syndrome; GM1 Gangliosidosis
Interventions: Drug: Clofarabine; Procedure: Total body Irradiation; Drug: Melphalan
Sponsors: Masonic Cancer Center, University of Minnesota; Masonic Cancer Center, University of Minnesota
Recruiting - verified October 2011 - Condition: Neimann-Pick Disease
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified November 2011 - Conditions: Mevalonic Aciduria; Mevalonate Kinase Deficiency; Immune System Diseases; Periodic Fever Syndromes, Hereditary; Lipid Metabolism, Inborn Errors
Intervention:
Sponsors: Oregon Health and Science University; Oregon Health and Science University
Recruiting - verified March 2012 - Condition: Lipoidosis
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified April 2012 - Conditions: Abnormalities; Inborn Errors of Metabolism; Mental Retardation; Muscle Hypotonia; Smith Lemli Opitz Syndrome
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified November 2010 - Conditions: Abetalipoproteinemia; Atherosclerosis; Healthy; Inborn Errors Lipid Metabolism
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified December 2011
 |
Join Clinical Trials That Study Cholesterol and Other Fats |
